Yuka Ishikawa

2.6k total citations
41 papers, 1.6k citations indexed

About

Yuka Ishikawa is a scholar working on Molecular Biology, Genetics and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Yuka Ishikawa has authored 41 papers receiving a total of 1.6k indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Molecular Biology, 12 papers in Genetics and 11 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Yuka Ishikawa's work include Muscle Physiology and Disorders (12 papers), Neurogenetic and Muscular Disorders Research (11 papers) and Respiratory Support and Mechanisms (8 papers). Yuka Ishikawa is often cited by papers focused on Muscle Physiology and Disorders (12 papers), Neurogenetic and Muscular Disorders Research (11 papers) and Respiratory Support and Mechanisms (8 papers). Yuka Ishikawa collaborates with scholars based in Japan, United States and Russia. Yuka Ishikawa's co-authors include John R. Bach, Ryoji Minami, Yukitoshi Ishikawa, H Ogata, Toshihiko Miura, Satoshi Hamada, Kozo Hanayama, Satoshi Deyama, Soichiro Ide and Masamichi Satoh and has published in prestigious journals such as The Journal of Physical Chemistry B, Neurology and CHEST Journal.

In The Last Decade

Yuka Ishikawa

39 papers receiving 1.5k citations

Peers

Yuka Ishikawa
Timothy J. England United Kingdom
Forbes H. Norris United States
Amir Moheet United States
Carmel Armon United States
Y Bureau Canada
Timothy J. England United Kingdom
Yuka Ishikawa
Citations per year, relative to Yuka Ishikawa Yuka Ishikawa (= 1×) peers Timothy J. England

Countries citing papers authored by Yuka Ishikawa

Since Specialization
Citations

This map shows the geographic impact of Yuka Ishikawa's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yuka Ishikawa with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yuka Ishikawa more than expected).

Fields of papers citing papers by Yuka Ishikawa

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yuka Ishikawa. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yuka Ishikawa. The network helps show where Yuka Ishikawa may publish in the future.

Co-authorship network of co-authors of Yuka Ishikawa

This figure shows the co-authorship network connecting the top 25 collaborators of Yuka Ishikawa. A scholar is included among the top collaborators of Yuka Ishikawa based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yuka Ishikawa. Yuka Ishikawa is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Bach, J R, et al.. (2025). Continuous Ventilatory Support Without Hospitalization or Tracheotomies. American Journal of Physical Medicine & Rehabilitation. 105(2). 143–150.
2.
Gonçalves, Miguel, et al.. (2021). Continuous noninvasive ventilatory support outcomes for patients with neuromuscular disease: a multicenter data collaboration. Pulmonology. 27(6). 509–517. 10 indexed citations
3.
Ishikawa, Yuka & Tomoyuki Furuyashiki. (2021). The impact of stress on immune systems and its relevance to mental illness. Neuroscience Research. 175. 16–24. 29 indexed citations
4.
Ishikawa, Yuka, et al.. (2017). Rapid and sustained antidepressant effects of resolvin D1 and D2 in a chronic unpredictable stress model. Behavioural Brain Research. 332. 233–236. 44 indexed citations
5.
Deyama, Satoshi, et al.. (2017). Resolvin D1 and D2 Reverse Lipopolysaccharide-Induced Depression-Like Behaviors Through the mTORC1 Signaling Pathway. The International Journal of Neuropsychopharmacology. 20(7). 575–584. 86 indexed citations
6.
Morii, Hideaki & Yuka Ishikawa. (2012). Cloning and nucleotide sequence analysis of the chloramphenicol and erythromycin resistance genes on a transferable R plasmid from the fish pathogen Photobacterium damselae subsp. piscicida. Nagasaki University's Academic Output SITE (Nagasaki University). 93. 41–50. 3 indexed citations
7.
Bach, John R., et al.. (2012). Changing Trends in the Management of End-Stage Neuromuscular Respiratory Muscle Failure. American Journal of Physical Medicine & Rehabilitation. 92(3). 267–277. 72 indexed citations
8.
Ishikawa, Yuka, Toshihiko Miura, Yukitoshi Ishikawa, et al.. (2010). Duchenne muscular dystrophy: Survival by cardio-respiratory interventions. Neuromuscular Disorders. 21(1). 47–51. 206 indexed citations
9.
Ishikawa, Yuka & J R Bach. (2010). Physical medicine respiratory muscle aids to avert respiratory complications of pediatric chest wall and vertebral deformity and muscle dysfunction.. PubMed. 46(4). 581–97. 7 indexed citations
10.
Hamada, Satoshi, et al.. (2010). Indicators for ventilator use in Duchenne muscular dystrophy. Respiratory Medicine. 105(4). 625–629. 23 indexed citations
11.
Ogata, H, Yuka Ishikawa, Yukitoshi Ishikawa, & Ryoji Minami. (2008). Beneficial effects of beta-blockers and angiotensin-converting enzyme inhibitors in Duchenne muscular dystrophy. Journal of Cardiology. 53(1). 72–78. 97 indexed citations
12.
Bach, John R., Miguel Gonçalves, Yuka Ishikawa, et al.. (2008). A Ventilator Requirement Index. American Journal of Physical Medicine & Rehabilitation. 87(4). 285–291. 6 indexed citations
13.
Ishikawa, Yuka, et al.. (2008). Cough Augmentation in Duchenne Muscular Dystrophy. American Journal of Physical Medicine & Rehabilitation. 87(9). 726–730. 40 indexed citations
14.
Ogata, H, Satoshi Nakatani, Yuka Ishikawa, et al.. (2006). Myocardial strain changes in Duchenne muscular dystrophy without overt cardiomyopathy. International Journal of Cardiology. 115(2). 190–195. 38 indexed citations
15.
Sato, Kazuki, et al.. (2002). [Changes in the clinical picture of Fukuyama type. Congenital muscular dystrophy in its advanced stage: effectiveness of mechanical ventilation systems].. PubMed. 34(4). 330–5. 2 indexed citations
16.
Takeshima, Yasuhiro, Hiroko Wada, Mariko Yagi, et al.. (2001). Oligonucleotides against a splicing enhancer sequence led to dystrophin production in muscle cells from a Duchenne muscular dystrophy patient. Brain and Development. 23(8). 788–790. 65 indexed citations
17.
Kanaya, Kohei, et al.. (2001). Correlation between Progression of Spinal Deformity and Pulmonary Function in Duchenne Muscular Dystrophy. Journal of Pediatric Orthopaedics. 21(1). 113–116. 25 indexed citations
18.
Ishikawa, Yuka, John R. Bach, & Ryoji Minami. (1999). Cardioprotection for Duchenne’s muscular dystrophy. American Heart Journal. 137(5). 895–902. 103 indexed citations
19.
Bach, John R., et al.. (1997). Prevention of Pulmonary Morbidity for Patients With Duchenne Muscular Dystrophy. CHEST Journal. 112(4). 1024–1028. 347 indexed citations
20.
Ishikawa, Yuka, John R. Bach, Radha Sarma, et al.. (1995). Cardiovascular Considerations in the Management of Neuromuscular Disease. Seminars in Neurology. 15(1). 93–108. 9 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026